Appointment booking for Dr. Joshlene Sandhu, OD is currently not available.Dr. Joshlene Sandhu, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Joshlene Sandhu, OD (she/her) is a Optometrist in Bellevue, WA with over 18 years of experience. What is your opinion of Dr. Joshlene Sandhu, OD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Joshlene Sandhu, OD has received over $1,347 which includes payments from the following companies:
$600.52 from Bausch & Lomb, a division of Bausch Health US, LLC
$169.09 from Alcon Laboratories Inc
$74.08 from Valeant Pharmaceuticals North America LLC
$73.89 from Shire North American Group Inc
$62.20 from Mallinckrodt LLC
$61.37 from The Walman Optical Company
$51.12 from CooperVision Inc.
$50.74 from MacuLogix, Inc.
$39.55 from Mallinckrodt Hospital Products Inc.
$30.80 from Johnson & Johnson Vision Care, Inc.
$24.98 from Kala Pharmaceuticals, Inc.
$23.81 from Akorn Inc.
$23.62 from Aerie Pharmaceuticals, Inc.
$22.46 from Johnson & Johnson Surgical Vision, Inc.
$21.48 from Visioneering Technologies, Inc.
$17.60 from Sun Pharmaceutical Industries Inc.
Payments received by Dr. Joshlene Sandhu, OD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!